Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03357757
Title Avelumab With Valproic Acid in Virus-associated Cancer (LATENT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AHS Cancer Control Alberta
Indications

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

nasopharynx carcinoma

penis squamous cell carcinoma

non-Hodgkin lymphoma

vaginal squamous tumor

Hodgkin's lymphoma

squamous cell carcinoma

vulva squamous cell carcinoma

anal squamous cell carcinoma

Therapies

Avelumab + Valproic acid

Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Recruiting Edmonton Alberta T6G 1Z2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field